Search
for
Sort by
Research 451–480 of 1000+
- Polycystic ovarian syndrome: Proposal for an evidence -based management plan for an electronic patient record system
- The pediatric origins of polycystic ovary syndrome
- Early onset androgenic alopecia: not a cosmetic problem but a sign of life time risk factors. Male phenotypic equivalent of polycystic ovarian syndrome: Is There a Male Phenotype of PCOS
- Gonadal profile in men with early-onset androgenetic alopecia: does a male PCOS-equivalent syndrome exist?
- Mutations in SREBF1, Encoding Sterol Regulatory Element Binding Transcription Factor 1, Cause Autosomal-Dominant IFAP Syndrome
- Comprehensive Transcriptome Profiling of Balding and Non-Balding Scalps in Trichorhinophalangeal Syndrome Type I Patient
- Improvement of Skin Lesions in an Adult with CHILD Syndrome Treated with 2% Ketoconazole Cream
- The Lipid Profiles in Different Characteristics of Women with PCOS and the Interaction Between Dyslipidemia and Metabolic Disorder States: A Retrospective Study in Chinese Population
- Cardiovascular Risk Factors in Bulgarian Patients with Polycystic Ovary Syndrome and/or Obesity
- miR-761-hepcidin/Gpx4 pathway contribute to unexplained liver dysfunction in polycystic ovary syndrome by regulating liver iron overload and ferroptosis
- Serum lipid profile and insulin resistance in women with polycystic ovary syndrome (PCOS)
- Are Women with Polycystic Ovary Syndrome at Increased Risk of Alzheimer Disease? Lessons from Insulin Resistance, Tryptophan and Gonadotropin Disturbances and Their Link with Amyloid-Beta Aggregation
- Analysis of LncRNA-mRNA Co-Expression Profiles in Patients With Polycystic Ovary Syndrome: A Pilot Study
- Changes in the serum metabolomics of polycystic ovary syndrome before and after compound oral contraceptive treatment
- A review on polyherbal and supplemental approach to treat Polycystic Ovarian Syndrome
- Androgen excess: a hallmark of polycystic ovary syndrome
- ARTIFICIAL INTELLIGENCE AND THE DIAGNOSTIC INVISIBILITY OF WOMEN’S METABOLIC DISORDERS: A NARRATIVE REVIEW OF SOCIO-TECHNICAL CHALLENGES IN PCOS/PMOS RECOGNITION
- Serum Metabolomics Study of Polycystic Ovary Syndrome Based on Liquid Chromatography–Mass Spectrometry
- Use of ethinylestradiol/drospirenone combination in patients with the polycystic ovary syndrome
- UHPLC/Q-TOFMS-based plasma metabolomics of polycystic ovary syndrome patients with and without insulin resistance
- The eye and the skin in endocrine metabolic diseases
- Co-administration of 5α-reductase Inhibitors Worsens the Adverse Metabolic Effects of Prescribed Glucocorticoids
- Activation of nuclear factor κB in response to cream ingestion is related to ovarian androgen hypersecretion in polycystic ovary syndrome
- Polycystic Ovarian Syndrome: A Breakthrough Etiology, Symptoms and Therapy
- Mitochondrial Dysfunction in Lichen Planopilaris with Focus on Oxidative Stress and Metabolic Reprogramming
- Evaluation of Glutathione-Related Antioxidant Enzyme Activity in Patients with Polycystic Ovary Syndrome (PCOS) and Investigation of Clinical Correlations
- Metformin effects on Polycystic Ovarian Syndrome
- A study on clinical correlation with Hyperinsulinemia in polycystic ovary Syndrome
- History of discovery of polycystic ovary syndrome
- Silicon-Related Syndrome in Dialysis Patients